BABA is having its best day in nearly a year. Up 11% as of midday Wednesday, the stock is doing something it hasn’t managed in months: moving on its own terms, not just reacting to macro noise.
The trigger was a pre-earnings analyst briefing that landed early Wednesday morning. Market watchers pointed to the briefing Alibaba held with analysts as the main catalyst, with the company indicating narrowing losses in its hotly competitive instant-commerce business during the June quarter while overall profitability held steady. That’s a big deal. Instant commerce has been the biggest drag on Alibaba’s margins — the company’s fiscal Q4 2026 report showed adjusted EBITA dropping 84% to $740 million on a $123 million operating loss, even as revenue grew to $35.3 billion. The signal that the bleeding is slowing is enough to get the bulls moving.
But there’s a second layer here, and it might matter more than the first.
Alibaba’s artificial intelligence and cloud business received a substantial boost alongside the margin news, with a market research report revealing that Alibaba Cloud secured a commanding 40% share of China’s full-stack AI cloud market, outpacing its top domestic competitors combined. That number is significant. The global AI trade has been almost entirely priced through U.S. and South Korean chips. Alibaba is offering a different angle.
The rally also reflected a broader rotation trade gathering pace across Asia, as investors pulled money from the chipmakers that powered this year’s gains in South Korea and Taiwan and looked for cheaper ways to participate in the AI boom. Chinese megacaps, which had fallen out of favor in recent months, are drawing fresh interest as investors search for less stretched valuations.
The valuation math is hard to ignore. Fundamentally, Alibaba is not priced like a bubble name. A price-to-earnings ratio near 15.3 and price-to-sales around 1.9 sit closer to value than momentum territory. For a company running 40% cloud growth and controlling nearly half the domestic AI cloud market, that’s a mismatch the market is starting to correct.
Slight tangent, but it matters: a U.S. District Judge granted Alibaba a temporary reprieve from a Pentagon-linked law, letting its U.S. lobbying activities continue while the rule faces a constitutional review. Alibaba also announced plans to partner with Eli Lilly to market the oral GLP-1 drug orforglipron in China. Multiple catalysts in a single morning — that’s not coincidence.
What Actually Determines the Next Move
Investors are looking ahead to Alibaba’s estimated August 28 earnings report, where Wall Street expects earnings per share of $2.51, up from $2.06 a year earlier, on revenue projected at $38.72 billion compared with $34.57 billion in the prior-year quarter.
The company’s Cloud Intelligence Group revenue grew 38% last quarter, and AI-related product revenue reached 30% of external cloud revenue for the 11th consecutive quarter of triple-digit AI growth. That’s not a speculative story. That’s a pattern.
The bear case is real too. Alibaba faces compounding legal and reputational damage following reports alleging the company illicitly accessed Anthropic’s AI model using thousands of fraudulent accounts. Plus, Chinese equity risk is never fully priced until it is. One day up 11% is not a thesis — it’s a signal worth investigating.
The question worth sitting with: is this a rotation trade that lasts a week, or the beginning of a sustained re-rating of Chinese AI infrastructure at a fraction of U.S. multiples? August 28 will start to answer that.
For informational purposes only.
